Artificial Intelligence In MRI Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 1.65 Billion |
| Market Size (2030) | USD 4.18 Billion |
| CAGR (2025 - 2030) | 20.45 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Artificial Intelligence In MRI Market Analysis
The Artificial Intelligence In MRI Market size is estimated at USD 1.65 billion in 2025, and is expected to reach USD 4.18 billion by 2030, at a CAGR of 20.45% during the forecast period (2025-2030).
The factors driving the growth of the market are improved diagnostic accuracy and treatment planning offered by AI-based MRI and the increased shift of doctors toward AI-based techniques.
Various research articles have been studied to understand the importance of AI in MRI scanning, which is likely to propel the market growth during the forecast period. For instance, in an article published by BMC Musculoskeletal Disorders in June 2024, the researchers found that the AI-assisted MRI Mask R-CNN model reliably identifies surgical target areas in pediatric hip and periarticular infections, providing a faster and more convenient option. This technology aids inexperienced physicians in pre-treatment assessments, lowering the chances of missed or incorrect diagnoses. As a result, improved diagnostic accuracy and treatment planning offered by AI-based MRI are driving the growth of this market.
The increasing shift of doctors toward AI-based techniques also contributes to market growth. For instance, an article published by the journal BMC Health Services Research in March 2022 stated that in a survey conducted among 114 German radiologists, 81% of them opted for AI-based diagnostic imaging tools in their routine diagnostics as these tools save time and provide quality results. Thus, the increasing shift of doctors and physicians to AI-based techniques is driving the growth of the market.
Also, the launch of advanced AI-based MRI products and the regulatory approvals are expected to drive market growth during the forecast period. For instance, in October 2022, Quibim, a company designing pioneering AI tools, received MDR (Class II B) and UKCA (UK Conformity Assessment) certifications to commercialize QP-Prostate in the European and British markets. QP-Prostate is an innovative software that uses AI to streamline prostate MRI interpretation and pre-populate radiology reports.
Thus, the market is expected to grow significantly during the forecast period due to increased advantages of AI-based MRI solutions and elevated strategic activities. However, the slow regulatory approval process and the high cost of AI-based equipment may slow down the growth of the market.
Artificial Intelligence In MRI Market Trends
The Cardiovascular Segment is Expected to Have a Notable Growth in the Market During the Forecast Period
The cardiovascular segment is expected to witness significant growth during the forecast period owing to the increasing use of artificial intelligence in MRI to diagnose a wide range of heart conditions. These include coronary heart disease, congenital heart disease, inherited heart conditions such as hypertrophic or dilated cardiomyopathy, heart valve disease, and cardiac tumors. The increasing prevalence of these heart diseases and the efficacy of artificial intelligence in MRI in detecting these diseases is driving the growth of this segment.
AI is revolutionizing the field of medical imaging and, in particular, cardiovascular magnetic resonance (CMR) by providing deep learning solutions for image acquisition, reconstruction, and analysis, ultimately supporting clinical decision-making. For instance, an article published by the National Centre for Biotechnology Information (NCBI) in January 2022 reported that AI has been envisaged as a useful tool to accelerate CMR imaging acquisition, analysis, and reporting while introducing new diagnostic and prognostic biomarkers. Thus, such advancements in artificial intelligence in CMR imaging are driving the growth of this segment.
The high number of cardiovascular disease (CVD) surgical procedures is also expected to drive the growth of the market. For instance, according to the World Heart Report 2023, more than half a billion people worldwide continue to be affected by cardiovascular diseases globally. The prevalence of cardiovascular disease, diabetes, and end-stage renal disease is expected to drive the market. According to CDC data updated in July 2022, coronary heart disease is the most common type of heart disease, and approximately 20.1 million adults aged 20 and older have the disease in the United States. The high number of cardiovascular diseases is expected to necessitate AI-based advanced MRI, which will drive the market's growth over the next few years.
Also, new product launches and technological developments are driving the growth of this segment. For instance, in October 2022, Philips received clearance from the United States Food and Drug Administration (US FDA) for its artificial intelligence MR platform to detect cancerous tumors in the head and neck.
Thus, the increased incidence of cardiovascular diseases (CVDs) and the efficacy of AI in MRI in detecting the same, along with increasing R&D investments and new product launches, are boosting the growth of this segment during the forecast period.
North America is Expected to Hold a Significant Market Share During the Forecast Period
North America is expected to grow significantly during the forecast period due to technological developments, better medical and diagnostic facilities, highly trained medical professionals, and increased R&D investment.
Technological developments are driving the growth of this market in the region. For instance, in November 2022, Subtle Medical reported its AI-powered software solutions, SubtleMR and SubtlePET, with a robust pipeline of new products in R&D at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). Subtle Medical's solutions provide hospitals and imaging centers the flexibility to deliver faster, higher-quality PET and MRI exams. This product offers an improved MRI image product. Thus, such development in AI-driven software is increasing the efficiency of MRI, driving the growth of this market in the region.
Similarly, the region is marked by better medical and diagnostic facilities. For instance, in November 2023, Canada's inaugural 15.2 Tesla magnetic resonance imaging (MRI) system was installed at the Centre for Functional and Metabolic Mapping (CFMM) within Western University's Schulich School of Medicine & Dentistry. Thus, better medical and diagnostic facilities are driving the growth of this market in the region.
Also, mergers, acquisitions, and partnerships are driving the growth of this market in the region. For instance, in July 2022, Viz.ai, an AI-powered disease detection and intelligent care coordination platform, partnered with Hyperfine Inc., creator of the US FDA-cleared point-of-care magnetic resonance imaging (MRI) device, Swoop. Thus, such partnerships are leading to the integration of two technologies for better patient access, thereby contributing to the studied market's growth.
Thus, owing to the increased adoption of AI-based MRI services and the installation and expansion of diagnostic centers across the region, the market will likely witness notable growth during the forecast period.
Artificial Intelligence In MRI Industry Overview
The artificial intelligence market in MRI is semi-consolidated due to a few market players working regionally and globally. Some companies in this market are IBM Corporation, Perimeter Medical Imaging AI, Resonance Health Ltd, Samsung Electronics Co. Ltd, Arterys Inc., and Koninklijke Philips NV.
Artificial Intelligence In MRI Market Leaders
-
Koninklijke Philips N.V.
-
Siemens Healthineers AG
-
IBM Corporation
-
Microsoft Corp (Nuance Communications Inc.)
-
Perimeter Medical Imaging AI
*Disclaimer: Major Players sorted in no particular order
Artificial Intelligence In MRI Market News
- May 2024: iHridAI, a Bengaluru-headquartered healthcare tech startup, unveiled its premier offering, HarmonyCVI. This cutting-edge product is tailored for precise cardiovascular evaluations. HarmonyCVI is an advanced AI/ML-driven diagnostic tool empowering cardiologists and radiologists to delve deeper into cardiac MRI scans and offering rapid insights and analysis.
- June 2023: GE HealthCare received United States Food and Drug Administration clearance for its Sonic DL. Based on deep learning, this cutting-edge technology is tailored to significantly speed up image acquisition in magnetic resonance imaging (MRI). Sonic DL paves the way for innovative imaging approaches, including the ability to conduct high-quality cardiac MRIs in one heartbeat. With this advancement, GE HealthCare further bolsters its position as a frontrunner in AI-driven healthcare solutions.
Artificial Intelligence In MRI Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Improved Diagnostic Accuracy and Treatment Planning Offered by AI-based MRI
4.2.2 Increased Shift of Doctors to the Artificial Intelligence-based Techniques
4.3 Market Restraints
4.3.1 Slow Regulatory Approval Process and High Cost of AI-based Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Clinical Applications
5.1.1 Musculoskeletal
5.1.2 Oncology
5.1.3 Liver
5.1.4 Cardiovascular
5.1.5 Neurology
5.1.6 Other Clinical Application
5.2 By Solution
5.2.1 Software
5.2.2 Services
5.3 By Technology
5.3.1 Deep Learning
5.3.2 Machine Learning
5.3.3 Computer Vision
5.3.4 NLP (Natural Language Processing)
5.3.5 Speech Recognition
5.3.6 Other Technologies
5.4 By Deployment Type
5.4.1 On-premise
5.4.2 Cloud-based
5.5 By End Users
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Other End Users
5.6 Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Rest of the World
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 IBM Corporation
6.1.2 Perimeter Medical Imaging AI
6.1.3 Resonance Health Ltd
6.1.4 Nanox (Zebra Medical Vision Inc.)
6.1.5 Samsung Electronics Co. Ltd
6.1.6 Arterys Inc.
6.1.7 Koninklijke Philips NV
6.1.8 Microsoft Corp. (Nuance Communications Inc.)
6.1.9 Siemens Healthineers AG
6.1.10 OrCam
6.1.11 Owkin Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Artificial Intelligence In MRI Industry Segmentation
As per the scope of the report, artificial intelligence (AI) is an intensive tool employed and incorporated into MRI machines for quantitative imaging. This advanced imaging technology has wide applications in neuroscience, oncology, cardiovascular, MSK, and body imaging.
The artificial intelligence in the MRI market is segmented by clinical applications, product type, technology, deployment type, end users, and geography. The market is segmented into oncology, musculoskeletal, liver, cardiovascular, neurology, and other clinical applications. Other clinical applications include sports medicine and rheumatology. By solution, the market is segmented into software and services. The market is segmented by technology into deep learning, machine learning, computer vision, natural language processing, speech recognition, and other technologies. Other technologies include scan planning optimization and automated segmentation. By deployment type, the market is segmented into on-premise and cloud-based. By end users, the market is segmented into hospitals, clinics, and other end users. Other end users include ambulatory surgery centers and diagnostic centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. For each segment, the market sizing and forecasts are done based on value (in USD).
| By Clinical Applications | |
| Musculoskeletal | |
| Oncology | |
| Liver | |
| Cardiovascular | |
| Neurology | |
| Other Clinical Application |
| By Solution | |
| Software | |
| Services |
| By Technology | |
| Deep Learning | |
| Machine Learning | |
| Computer Vision | |
| NLP (Natural Language Processing) | |
| Speech Recognition | |
| Other Technologies |
| By Deployment Type | |
| On-premise | |
| Cloud-based |
| By End Users | |
| Hospitals | |
| Clinics | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| Rest of the World |
Artificial Intelligence In MRI Market Research Faqs
How big is the Artificial Intelligence In MRI Market?
The Artificial Intelligence In MRI Market size is expected to reach USD 1.65 billion in 2025 and grow at a CAGR of 20.45% to reach USD 4.18 billion by 2030.
What is the current Artificial Intelligence In MRI Market size?
In 2025, the Artificial Intelligence In MRI Market size is expected to reach USD 1.65 billion.
Who are the key players in Artificial Intelligence In MRI Market?
Koninklijke Philips N.V., Siemens Healthineers AG, IBM Corporation, Microsoft Corp (Nuance Communications Inc.) and Perimeter Medical Imaging AI are the major companies operating in the Artificial Intelligence In MRI Market.
Which is the fastest growing region in Artificial Intelligence In MRI Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Artificial Intelligence In MRI Market?
In 2025, the North America accounts for the largest market share in Artificial Intelligence In MRI Market.
What years does this Artificial Intelligence In MRI Market cover, and what was the market size in 2024?
In 2024, the Artificial Intelligence In MRI Market size was estimated at USD 1.31 billion. The report covers the Artificial Intelligence In MRI Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Artificial Intelligence In MRI Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Artificial Intelligence In MRI Industry Report
Statistics for the 2025 Artificial Intelligence In MRI market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Artificial Intelligence In MRI analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
Artificial Intelligence In MRI Market Report Snapshots
